Literature DB >> 28382876

Assessment of Risks Posed to VAD Patients During Disasters.

Katherine J Davis1, Genevieve O'Shea2, Michael Beach1.   

Abstract

Ventricular assist devices (VADs) are an Advanced Life Support for patients with heart failure. These patients are particularly vulnerable in the event of a disaster. A hazard vulnerability analysis (HVA) was conducted to determine areas of susceptibility for these patients. Lack of electrical power, limited access to medications and anticoagulation, dehydration, extreme temperature and weather environments, conditions which predispose to infection, and evacuation transport are all identified circumstances that place these patients at an increased risk for harm and death. Future preparations in disaster planning are needed to address and mitigate these risks. Davis KJ , O'Shea G , Beach M . Assessment of risks posed to VAD patients during disasters. Prehosp Disaster Med. 2017;32(4):457-461.

Entities:  

Keywords:  DDC Dual Drive Console; HVA hazard vulnerability analysis; LVAD Left Ventricular Assist Device; PVAD Paracorporeal Ventricular Assist Device; VAD ventricular assist device; preparedness; disaster planning; hazard vulnerability analysis; mitigation; ventricular assist device

Mesh:

Year:  2017        PMID: 28382876     DOI: 10.1017/S1049023X17006379

Source DB:  PubMed          Journal:  Prehosp Disaster Med        ISSN: 1049-023X            Impact factor:   2.040


  2 in total

1.  Risk assessment of infection control in operating room based on hazard vulnerability and refined process management.

Authors:  Ling Wang; Yan Chen; Chunxiang Xia; Ling Wu; Yan Song
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Social Vulnerability and Access of Local Medical Care During Hurricane Harvey: A Spatial Analysis.

Authors:  David S Rickless; Grete E Wilt; J Danielle Sharpe; Noelle Molinari; William Stephens; Tanya Telfair LeBlanc
Journal:  Disaster Med Public Health Prep       Date:  2021-03-15       Impact factor: 5.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.